Skip to main content

AXSM

Axsome Therapeutics, Inc.
Last price
$234.34
As of

Active signals for AXSM

Top institutional holders of AXSM (13F)

FundMarket value% portfolioQoQ
Point72 Asset Management, L.P.$71.8M0.09%>5000%
D. E. Shaw & Co., Inc.$33.4M0.02%,
RENAISSANCE TECHNOLOGIES LLC$31M0.05%+13.3%
RENAISSANCE TECHNOLOGIES LLC$27.8M0.04%-3.4%
TWO SIGMA INVESTMENTS, LP$26.6M0.04%+1674.1%
RENAISSANCE TECHNOLOGIES LLC$18.2M0.02%,
CITADEL ADVISORS LLC$14.6M0.00%-24.6%
CITADEL ADVISORS LLC$12.9M0.00%,
Bridgewater Associates, LP$9.6M0.04%+20.0%
Bridgewater Associates, LP$8.7M0.03%,
D. E. Shaw & Co., Inc.$1.6M0.00%-96.8%
TWO SIGMA INVESTMENTS, LP$997K0.00%,
Point72 Asset Management, L.P.$804K0.00%+0.0%
D. E. Shaw & Co., Inc.$625K0.00%-57.5%
TWO SIGMA INVESTMENTS, LP$625K0.00%-97.5%
Point72 Asset Management, L.P.$534K0.00%,

Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.

Recent SEC filings, AXSM

See more AXSM signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track AXSM in your watchlist and get notified the moment a new signal fires.

Track AXSM on Kresmion →